Full CoverageTop news
U.S. secures 300 million doses of potential AstraZeneca COVID-19 vaccine
By Kate Holton & Guy Faulconbridge
AstraZeneca receives $1 billion in U.S. funding for Oxford University coronavirus vaccine
By Vicky McKeever
AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial
AstraZeneca Receives $1 Billion From U.S. Government To Produce Coronavirus Vaccine
By Isabel Togoh
All coverage
AstraZeneca scores $1.2B from U.S., signs up to deliver hundreds of millions of COVID-19 vaccines
By Eric Sagonowsky
$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine (Published 2020)
By David D. Kirkpatrick
How one Indian company could be world's door to a COVID-19 vaccine
By Euan Rocha & Abhirup Roy